Kalaris Therapeutics, Inc. · NASDAQ:KLRS

Rtw Investments, LP reported a 5.70% stake in Kalaris Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 17, 2026

Rtw Investments, LP reported a 5.70% stake in Kalaris Therapeutics, Inc., 1,300,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).

Stake
5.70%
Shares
1,300,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
RTW Investments, LP5.70%1,300,000
Roderick Wong5.70%1,300,000

Source

View original at SEC

Related